AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27085323 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine (Gem) 1000 mg/m²
Number of subjects: 861
Study 25129475 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with target-controlled infusion (TIVA-TCI)
Number of subjects: 102
Study 25129475 — intervention group
Group type: COMPARATOR
Intervention: Balanced inhalation anaesthesia (BAL)
Number of subjects: 102
Study 25129475 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic prostatectomy (RALP)
Number of subjects: 102
Study 25129475 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic prostatectomy (LRP)
Number of subjects: 102
Study 22198451 — intervention group
Group type: EXPERIMENTAL
Intervention: Asenapine
Number of subjects: 949
Study 22198451 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 949
Study 19692134 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of glimepiride (CONT)
Number of subjects: 26
Study 17683704 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive care of cardiovascular risk factors (CVRF) management
Number of subjects: 247
Study 17683704 — intervention group
Group type: COMPARATOR
Intervention: Usual care according to National Health Service recommendations
Number of subjects: 247
Study 15897583 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed muffin (25 g daily)
Number of subjects: 32
Study 15897583 — intervention group
Group type: COMPARATOR
Intervention: Placebo muffin
Number of subjects: 32
Study 12413616 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg followed by misoprostol 800 microg vaginally on the same day
Number of subjects: 80
Study 9593980 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalised regression neural network (GRNN) analysis during Necker cube reversals
Number of subjects: 9
Study 9593980 — intervention group
Group type: EXPERIMENTAL
Intervention: Necker cube reversal condition
Number of subjects: 9
Study 9593980 — intervention group
Group type: EXPERIMENTAL
Intervention: Coherent MEG activity
Number of subjects: 9
Study 8452271 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean arterial pressure maintained at 50 +/- 5 mm Hg
Number of subjects: 40
Study 8452271 — intervention group
Group type: COMPARATOR
Intervention: Mean arterial pressure maintained at 60 +/- 5 mm Hg
Number of subjects: 40
Study 2878457 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.54 g/kg ethanol
Number of subjects: 13
Study 2878457 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 g/kg ethanol
Number of subjects: 13
Study 2878457 — intervention group
Group type: COMPARATOR
Intervention: 0 g/kg ethanol (control)
Number of subjects: 13
Study 30741616 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 36
Study 30741616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 27232953 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the right posterolateral cerebellum
Number of subjects: 76
Study 27232953 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS over the right posterolateral cerebellum
Number of subjects: 76
Study 27232953 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 76
Study 24670314 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES intervention followed by conventional treatment (thermaltactile stimulation with intensive repetition of a dry-swallow task)
Number of subjects: 26
Study 24670314 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment without NMES
Number of subjects: 26
Study 22341079 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% EDTA
Number of subjects: 45
Study 22341079 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% citric acid
Number of subjects: 45
Study 22341079 — intervention group
Group type: EXPERIMENTAL
Intervention: BioPure MTAD
Number of subjects: 45
Study 22341079 — intervention group
Group type: EXPERIMENTAL
Intervention: SmearClear
Number of subjects: 45
Study 22341079 — intervention group
Group type: COMPARATOR
Intervention: 3% NaOCl (control)
Number of subjects: 45
Study 21034484 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine-2-receptor antagonists (H2RA)
Number of subjects: 2092
Study 21034484 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate
Number of subjects: 2092
Study 18326251 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine solution
Number of subjects: 90
Study 18326251 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine solution
Number of subjects: 90
Study 18326251 — intervention group
Group type: COMPARATOR
Intervention: Control group (no EA)
Number of subjects: 90
Study 15716665 — intervention group
Group type: EXPERIMENTAL
Intervention: Low microparticle diet
Number of subjects: 83
Study 15716665 — intervention group
Group type: COMPARATOR
Intervention: Normal microparticle diet
Number of subjects: 83
Study 12410512 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% (5-25 ml) for local anesthesia of the groin
Number of subjects: 126
Study 10220626 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (4 boluses of 50 mg each every 2 minutes, then an infusion of 3 mg/min for 12 hours, then 2 mg/min for 36 hours)
Number of subjects: 903
Study 10220626 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 903
Study 10220626 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of prophylactic lidocaine
Number of subjects: 903
Study 7717812 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximally flexed neck with pelvic stabilization through muscle contraction
Number of subjects: 30
Study 2380510 — intervention group
Group type: COMPARATOR
Intervention: Ritodrine
Number of subjects: 62
Study 2380510 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 62
Study 7016629 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 0.025% ointment
Number of subjects: 32
Study 7016629 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 0.01% ointment (maintenance treatment)
Number of subjects: 32
Study 7016629 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone-17-valerate 0.1% ointment
Number of subjects: 32
Study 30810228 — intervention group
Group type: EXPERIMENTAL
Intervention: Finn Chamber technique
Number of subjects: 3119
Study 30810228 — intervention group
Group type: COMPARATOR
Intervention: TRUE Test technique
Number of subjects: 3119
Study 28030374 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Centered Personal Health Record and Patient Portal Implementation Toolkit Plus (MyHealthPortal)
Number of subjects: 74
Study 28030374 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 74
Study 25854593 — intervention group
Group type: EXPERIMENTAL
Intervention: Myoinositol
Number of subjects: 0
Study 25854593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23723410 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT)
Number of subjects: 40
Study 23723410 — intervention group
Group type: COMPARATOR
Intervention: Anterior stromal puncture (ASP)
Number of subjects: 40
Study 23723410 — intervention group
Group type: EXPERIMENTAL
Intervention: Both AMT and ASP
Number of subjects: 40
Study 21840680 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacam Eye Scanner measurements of corneal elevation
Number of subjects: 555
Study 21840680 — intervention group
Group type: EXPERIMENTAL
Intervention: Country-specific thresholds
Number of subjects: 555
Study 19562253 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg of methylprednisolone pre-operatively
Number of subjects: 20
Study 19562253 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study 17415706 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcholinesterase inhibitors (AChEIs)
Number of subjects: 0
Study 17415706 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory compounds (rofecoxib)
Number of subjects: 0
Study 17415706 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex steroid hormones (testosterone, estrogens)
Number of subjects: 0
Study 17415706 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidants (tocopherol)
Number of subjects: 0
Study 15557906 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-bonded Dacron (HBD)
Number of subjects: 209
Study 15557906 — intervention group
Group type: COMPARATOR
Intervention: Polytetrafluoroethylene (PTFE)
Number of subjects: 209
Study 11274349 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-mg nicotine gum
Number of subjects: 22
Study 11274349 — intervention group
Group type: COMPARATOR
Intervention: placebo gum
Number of subjects: 22
Study 9779839 — intervention group
Group type: EXPERIMENTAL
Intervention: sulfasalazine (SASP)
Number of subjects: 200
Study 9779839 — intervention group
Group type: COMPARATOR
Intervention: penicillamine (PEN)
Number of subjects: 200
Study 7575227 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin
Number of subjects: 100
Study 7575227 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 100
Study 2626520 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluphenazine (FLU)
Number of subjects: 0
Study 2626520 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazine decanoate (FD)
Number of subjects: 0
Study 769555 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (600 mg every 6 hours)
Number of subjects: 0
Study 769555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29991214 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports therapy and recreation exercise program
Number of subjects: 208
Study 28430785 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftopidil 75 mg
Number of subjects: 150
Study 28430785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 25413896 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 54
Study 25413896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 24094282 — intervention group
Group type: EXPERIMENTAL
Intervention: Negativity during couple interaction
Number of subjects: 128
Study 24094282 — intervention group
Group type: EXPERIMENTAL
Intervention: Low anxiety or little history of chronic arguing
Number of subjects: 128
Study 24094282 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated levels of anxiety or chronic arguing
Number of subjects: 128
Study 24094282 — intervention group
Group type: EXPERIMENTAL
Intervention: Low warmth in couple interaction
Number of subjects: 128
Study 21353463 — intervention group
Group type: EXPERIMENTAL
Intervention: Unimanual task with typically developing children
Number of subjects: 37
Study 21353463 — intervention group
Group type: COMPARATOR
Intervention: Children with CP in unimanual task
Number of subjects: 37
Study 21353463 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimanual task with CP children (more affected hand)
Number of subjects: 37
Study 21353463 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimanual task with CP children (less affected hand)
Number of subjects: 37
Study 19409858 — intervention group
Group type: EXPERIMENTAL
Intervention: GW406381 25 mg
Number of subjects: 209
Study 19409858 — intervention group
Group type: EXPERIMENTAL
Intervention: GW406381 50 mg
Number of subjects: 209
Study 19409858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study 17876866 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimosiamose disodium 100 mg
Number of subjects: 0
Study 17876866 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimosiamose disodium 200 mg
Number of subjects: 0
Study 17876866 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimosiamose disodium 300 mg
Number of subjects: 0
Study 17876866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15497369 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (20,000 IU of beta-carotene, 400 IU alpha-tocopherol acetate, 500 mg ascorbic acid, 100 microg selenium, and 30 mg zinc)
Number of subjects: 18
Study 15497369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 15497369 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 18
Study 11476126 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg/day
Number of subjects: 140
Study 11476126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 9784819 — intervention group
Group type: EXPERIMENTAL
Intervention: Insall proximal realignments or isolated lateral retinacular releases
Number of subjects: 16
Study 7874152 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index (GI) powdered food
Number of subjects: 6
Study 7874152 — intervention group
Group type: EXPERIMENTAL
Intervention: High glycemic index (GI) powdered food
Number of subjects: 6
Study 7874152 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index (GI) breakfast cereal
Number of subjects: 6
Study 7874152 — intervention group
Group type: EXPERIMENTAL
Intervention: High glycemic index (GI) breakfast cereal
Number of subjects: 6
Study 7874152 — intervention group
Group type: EXPERIMENTAL
Intervention: All test meals (low-GI and high-GI)
Number of subjects: 6
Study 3312397 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐HTP
Number of subjects: 45
Study 3312397 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 45
Study 3312397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 30086256 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical pentoxifylline (PTX) 5% ointment, applied twice daily for 14 days
Number of subjects: 112
Study 30086256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 28813696 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized home-based training program (6-week strength and functional home training)
Number of subjects: 34
Study 28813696 — intervention group
Group type: COMPARATOR
Intervention: Usual care (delayed start of training)
Number of subjects: 34
Study 26263797 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1 inspiratory to expiratory (I:E) ratio
Number of subjects: 26
Study 26263797 — intervention group
Group type: COMPARATOR
Intervention: 1:2 inspiratory to expiratory (I:E) ratio
Number of subjects: 26
Study 22000423 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 100
Study 22000423 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 100
Study 21896944 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow rate (SR) weight loss intervention (0.7% body weight per week)
Number of subjects: 23
Study 21896944 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast rate (FR) weight loss intervention (1.4% body weight per week)
Number of subjects: 23
Study 21896944 — intervention group
Group type: COMPARATOR
Intervention: Both groups (SR and FR)
Number of subjects: 23
Study 19324483 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous EPO administration
Number of subjects: 78
Study 19324483 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous EPO administration
Number of subjects: 78
Study 16964676 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg once daily for 48 weeks
Number of subjects: 224
Study 14742619 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral active stimulation (hf rTMS over LDLPC and sham lf rTMS over RDLPC)
Number of subjects: 41
Study 14742619 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral active stimulation (hf rTMS over LDLPC and lf rTMS over RDLPC)
Number of subjects: 41
Study 14742619 — intervention group
Group type: COMPARATOR
Intervention: Bilateral sham stimulation
Number of subjects: 41
Study 11111818 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosorba Immunoadsorption Column treatment (active treatment arm)
Number of subjects: 99
Study 11111818 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (apheresis only, control arm)
Number of subjects: 99
Study 9616826 — intervention group
Group type: EXPERIMENTAL
Intervention: Pristinamycin (1 g bid for 10-14 days)
Number of subjects: 180
Study 9616826 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-clavulanic acid (500 mg q.i.d. for 10-14 days)
Number of subjects: 180
Study 1570887 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with 12.5 mg hyperbaric 0.5% bupivacaine and postoperative immobilisation for either 6 or 24 hours.
Number of subjects: 202
Study 1570887 — intervention group
Group type: COMPARATOR
Intervention: Postoperative immobilisation for either 6 or 24 hours.
Number of subjects: 202
Study 2981129 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 9
Study 2981129 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31706805 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 74
Study 30677181 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty
Number of subjects: 0
Study 30677181 — intervention group
Group type: EXPERIMENTAL
Intervention: Kyphoplasty
Number of subjects: 0
Study 30677181 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal bracing
Number of subjects: 0
Study 30677181 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0
Study 30677181 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-osteoporotic medications
Number of subjects: 0
Study 30677181 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29948863 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 921
Study 29948863 — intervention group
Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 921
Study 26818733 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin in addition to usual care
Number of subjects: 0
Study 26818733 — intervention group
Group type: COMPARATOR
Intervention: Placebo in addition to usual care
Number of subjects: 0
Study 26818733 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0
Study 26818733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24505249 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular mass (LVM) tertiles
Number of subjects: 327
Study 24505249 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 327
Study 24505249 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual renal function
Number of subjects: 327
Study 24505249 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate binder therapy
Number of subjects: 327
Study 24505249 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous kidney transplantation
Number of subjects: 327
Study 24505249 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 327
Study 24505249 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin‐6 (Il‐6), high‐sensitivity C‐reactive protein (hsCRP), hepcidin‐25, connective tissue growth factor (CTGF)
Number of subjects: 327
Study 22523045 — intervention group
Group type: EXPERIMENTAL
Intervention: Background music with lyrics
Number of subjects: 102
Study 22523045 — intervention group
Group type: COMPARATOR
Intervention: Background music without lyrics
Number of subjects: 102
Study 18839400 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized Anxiety Disorder Severity Scale (GADSS) administered via telephone
Number of subjects: 223
Study 17442467 — intervention group
Group type: EXPERIMENTAL
Intervention: Pnc polysaccharide vaccine, Hemophilus influenzae type b conjugate vaccine, and tetanus toxoid
Number of subjects: 106
Study 17442467 — intervention group
Group type: COMPARATOR
Intervention: Tetanus toxoid only
Number of subjects: 106
Study 15194828 — intervention group
Group type: EXPERIMENTAL
Intervention: MC-4 vaccine
Number of subjects: 30
Study 15194828 — intervention group
Group type: COMPARATOR
Intervention: MPS-4 vaccine
Number of subjects: 30
Study 15194828 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher avidity antibody
Number of subjects: 30
Study 11115819 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glutamine (18 g/day)
Number of subjects: 70
Study 9856673 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status at diagnosis (body mass index standard deviation score - SDS)
Number of subjects: 1025
Study 8119688 — intervention group
Group type: EXPERIMENTAL
Intervention: ursodeoxycholic acid (13 to 15 mg/kg/day)
Number of subjects: 97
Study 8119688 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 97
Study 8119688 — intervention group
Group type: EXPERIMENTAL
Intervention: ursodeoxycholic acid
Number of subjects: 97
Study 2690289 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids
Number of subjects: 4198
Study 2690289 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 4198
Study 2690289 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids and placebo
Number of subjects: 4198
Study 1092516 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 7
Study 27706121 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory Integration Therapy (SIT) for 2 weeks, 5 times a week
Number of subjects: 28
Study 27706121 — intervention group
Group type: COMPARATOR
Intervention: Standard classes in kindergarten (Control group)
Number of subjects: 28
Study 31787369 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylcobalamin 500 μg and folic acid 400 μg once daily
Number of subjects: 279
Study 31787369 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 279
Study 31177890 — intervention group
Group type: EXPERIMENTAL
Intervention: Episiometer
Number of subjects: 50
Study 27832260 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal testosterone cream (IVT)
Number of subjects: 76
Study 27832260 — intervention group
Group type: COMPARATOR
Intervention: Estradiol vaginal ring (7.5 μg/d)
Number of subjects: 76
Study 25684217 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 684
Study 23595134 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense exercise protocol
Number of subjects: 14
Study 23595134 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D concentrations
Number of subjects: 14